What "Biocompatible" Actually Means

Biocompatibility is a material property, not a binary label. In dental materials science, the ISO 10993 standard defines biocompatibility as the ability of a material to perform its intended function without eliciting a harmful local or systemic response in the host. This is an engineering-level definition that addresses population-level safety.

Biological dentistry takes an additional, individualized step: recognizing that population-level biocompatibility does not guarantee individual-level biocompatibility. A material that is safe for 98% of patients may produce a delayed-type hypersensitivity reaction, a localized inflammatory response, or a systemic immune activation in the remaining 2%. For patients with autoimmune conditions, chemical sensitivities, or known material allergies, that 2% is not an acceptable risk — and laboratory testing exists to identify individual reactivity before any material is placed.

$200 – $500

For individual-specific biocompatibility laboratory testing (CLIFFORD or Biocomp). This is an out-of-pocket diagnostic cost; results are used to guide material selection for all future dental work — a one-time investment applicable across the full scope of any planned treatment.

Individual Biocompatibility Testing Platforms

CLIFFORD Consulting & Research (Colorado Springs, CO)

CLIFFORD testing is the most comprehensive dental material biocompatibility screen available in the United States. The process:

  1. A blood sample is drawn and sent to CLIFFORD's laboratory.
  2. The serum is analyzed for immune reactivity (IgG, IgE, and lymphocyte transformation testing) to the chemical constituents of over 16,000 individual dental material products, organized into chemical families.
  3. The report stratifies every tested material into a reactivity category: non-reactive, low reactivity, moderate reactivity, or high reactivity for that specific patient.
  4. Your biological dentist selects materials from the non-reactive list for all planned restorations.

The CLIFFORD database is updated continuously as new materials enter the market. A CLIFFORD report is typically valid for 3–5 years; retesting is recommended after major health changes (new autoimmune diagnoses, immunosuppressive therapy, significant illness).

Biocomp Laboratories

Biocomp offers a serum-based IgG, IgM, and IgA reactivity panel to a curated set of chemical categories relevant to dental materials. Less granular than CLIFFORD (it identifies reactivity to material categories rather than specific products), but less expensive and faster turnaround. Useful as an initial screen when CLIFFORD testing is cost-prohibitive; follow-up CLIFFORD testing can be prioritized to categories flagged as reactive on Biocomp.

Material Categories: Preferred vs. Avoided in Biological Practice

Preferred: Ceramic Restorations

Lithium disilicate (IPS e.max), feldspathic porcelain, and monolithic zirconia have consistently low reactivity profiles across patient populations. They are electrochemically inert, do not corrode, release no ions under physiological conditions, and show minimal inflammatory response in peri-dental tissue in long-term histological studies. Ceramic is the first choice in biological dentistry for crowns, onlays, veneers, and implant components.

Preferred: Nano-Hybrid and Nano-Filled Composite Resins

Modern composite resins — when free of bisphenol-A (BPA) and bisphenol-A dimethacrylate (bis-DMA) — have excellent biocompatibility profiles for the vast majority of patients. Biological dentists specify BPA-free composite formulations (some manufacturers explicitly certify BPA-free chemistry; others do not). For patients with documented methacrylate sensitivity, alternative material categories are selected via CLIFFORD testing.

Preferred: Glass Ionomer and Resin-Modified Glass Ionomer

For patients with methacrylate sensitivity where composite is contraindicated, glass ionomer cements provide a non-methacrylate bonding alternative for low-load areas, liners, and base applications. Glass ionomer's fluoride-releasing property is a secondary benefit for caries-prone patients.

Preferred: MTA (Mineral Trioxide Aggregate) and Biodentine

These bioactive calcium silicate cements are used in pulp capping, direct pulp therapy, apexification, and root perforation repair. Their outstanding biocompatibility — actively promoting hard tissue formation at the pulp interface — makes them the biological dentistry standard for any procedure involving pulp contact. They replace formaldehyde-containing pulp capping agents (Formocresol, Ledermix) that remain in use in conventional dental practice despite documented toxicity.

Avoided or Used with Caution: Amalgam

50% elemental mercury by weight. Continuous low-level vapor emission and peak emissions during placement and removal. The WHO, FDA, and multiple national health agencies now recommend avoiding amalgam in pregnant women, children under 6, and patients with kidney disease or neurological conditions. Biological dentists avoid amalgam categorically for all patients and apply the SMART protocol for safe removal of existing amalgams. See the SMART amalgam removal guide.

Avoided or Used with Caution: Nickel-Chromium and Cobalt-Chromium Alloys

Used as substructures in PFM crowns and bridges. Nickel is a documented contact allergen — among the most common causes of contact dermatitis in the general population. Cobalt and chromium are potential sensitizers and corrosion products that accumulate in peri-dental tissue. Biological dentists replace PFM crowns with full-ceramic alternatives and avoid nickel-containing alloys categorically.

Avoided or Used with Caution: Eugenol-Containing Cements

Zinc oxide eugenol (ZOE) cements — commonly used as temporary restorative materials and endodontic sealers — are cytotoxic to pulp cells at clinically relevant concentrations and inhibit the polymerization of composite resins placed over them. Biological dentists use eugenol-free temporary materials and non-eugenol endodontic sealers (calcium silicate, resin-based) as standard practice.

The Material Conversation to Have at Your First Appointment

Ask any biological or biomimetic dentist you consult: "Which composite do you use, and is it BPA-free?" and "Do you offer CLIFFORD or Biocomp testing before placing permanent restorations?" These two questions immediately reveal whether material biocompatibility is integrated into their standard of care or mentioned only as a marketing point.

Credentials to Verify

  • IAOMT
    International Academy of Oral Medicine and Toxicology — the scientific body that publishes the most rigorous evidence reviews on dental material toxicology, mercury, and biocompatibility protocols. IAOMT-affiliated dentists are trained in the toxicology of dental materials beyond what dental school curricula cover.
  • IABDM
    International Academy of Biological Dentistry and Medicine — IABDM member practices commit to biocompatible material selection, CLIFFORD or equivalent testing availability, and avoidance of materials with established toxicity profiles.

Frequently Asked Questions

Is CLIFFORD testing covered by insurance?

No — dental biocompatibility testing is not covered by dental insurance or most health insurance plans. It is an elective out-of-pocket diagnostic. Some health savings accounts (HSA/FSA) cover lab testing; confirm with your plan administrator.

Do I need CLIFFORD testing if I have no known allergies?

Not necessarily — for patients without autoimmune conditions, known material allergies, or systemic health concerns, the biological dentist's standard material panel (ceramic, BPA-free composite, MTA) is appropriate without individual testing. CLIFFORD testing is most valuable for patients with documented sensitivities or complex systemic health situations where material reactivity could have meaningful clinical consequences.

Are tooth-colored composite fillings safe?

Modern BPA-free nanofilled composites have well-characterized safety profiles and are considered biocompatible for the general population. The early concern about BPA leaching from bis-GMA composites has been largely addressed by manufacturers moving to alternative monomer chemistries. Patients with known methacrylate sensitivity should request CLIFFORD testing to identify compatible alternative materials before composite placement.